Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA’s dietary supplement program chief raised eyebrows at a botanical products conference citing low estimates on rates of compliance with the good manufacturing practices final rule and the new dietary ingredient notification requirements, as well as adverse event reporting.
You may also be interested in...
Medical Association's Diagnosis Of US Supplement Market Has Industry Asking For Second Opinion
AMA decides “to call for more stringent federal regulation of supplements—including increased oversight of manufacturing, marketing, product labeling, and adverse event reporting.” But NPA CEO Daniel Fabricant says supplements account for a fraction of the problems linked to drugs approved for sale in the US. "We don’t have a vitamin C crisis in America, we do have an opioid crisis."
Durbin Requests GAO Inquiry On Supplement Adverse Event Reports
Sen. Durbin says it is unclear how FDA’s adverse event reporting system works to protect consumer safety and asks GAO to investigate the agency’s collection and analysis of dietary supplement AERs.
FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth
FDA published a how-to guide to push dietary supplement firms toward tighter compliance with the requirement to submit serious adverse event reports to the agency.